Search
Utilizamos cookies para generar estadísticas que nos ayudan a mejorar la calidad de nuestro sitio web y su experiencia de usuario. Al hacer clic en «Aceptar todo», usted consiente el tratamiento de sus datos por parte de Acino y su transferencia a terceros. También puede personalizar su consentimiento para fines específicos de tratamiento de datos. Una vez que haya realizado su elección, haga clic en «Confirmar». Encontrará información detallada y podrá modificar sus preferencias en cualquier momento en nuestra Política de Privacidad .
Necessary Cookies Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics Cookies
We would like to set Google Analytics cookies to help us analyse the traffic on our website.
Precautionary Recall of Berifen® 75 Mg IM in Ecuador
Friday 16th October 2026
Recall Reference: Acino, part of Arcera is voluntarily recalling Berifen® 75 mg IM, with sanitary registration No. 2663-MEE-0417, lot 172380....
Notice Regarding Theft of Medication July 29, 2026
Wednesday 29th July 2026
To our customers, healthcare professionals, and the general public: Committed to safeguarding patient safety and maintaining the integrity of the...
Market Announcement. Labeling Update.
Monday 22nd June 2026
Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda. (“M8”) hereby announces anupdate to the labeling of product packaging sold in...
Market Announcement. NABOTA® Packaging Update.
Monday 25th May 2026
Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda. (“M8”), responsible for the exclusive importation and commercialization of NABOTA® (botulinum toxin...
Notice Regarding Theft of Medication March 23, 2025
Wednesday 11th March 2026
Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...
Notice Regarding Theft of Medication May 18, 2025
Wednesday 11th March 2026
Dear customers and healthcare professionals, our top priority is to ensure the quality, efficacy, and safety of those who use...
Report on Transparency and Pay Equity Between Women and Men
Wednesday 31st December 2025
Notice of Registration Cancellation for the Drug Ultraproct LDO (fluocortolone pivalate, lidocaine...
Thursday 13th November 2025
In accordance with Resolution RDC No. 18/2014, issued by Anvisa (the Brazilian Health Regulatory Agency), Moksha8 Brasil Indústria e Comércio...
Notice of Lisodren’s Registration Cancellation
Monday 6th January 2025
Moksha8 Brasil Indústria e Comércio de Medicamentos Ltda (“M8 Pharmaceuticals”) announces that on May 7, 2024, it requested that the...
Leadership Announcements and New Arcera Structure
Monday 2nd December 2024
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...